Bangkok: Medyceles Co., Ltd. has reinforced its status as the leading force in the Korean filler and botulinum toxin industry by hosting the Medyceles 360° Volume 4 event, which gathered doctors and beauty clinic owners from across Thailand. The comprehensive four-day event, held from August 18-21, 2026, aimed to elevate knowledge in botulinum toxin and aesthetic medicine, while showcasing the first-ever clinical trial results of Neuramis Deep Lidocaine for lip application.
According to Thai News Agency, Medyceles Co., Ltd., a prominent importer and distributor of aesthetic medical products in Thailand, continues to strengthen its business following sustained growth in the first half of the year. The company has outlined its strategy for the second half, aiming for 1 billion baht in sales for the third consecutive year. Neuronox, a Korean-made Botulinum Toxin Type A, serves as a key flagship product driving this growth.
Neuronox is prioritized by Medyceles for market development, knowledge building for doctors, and continuous support for partner clinics. Alongside Neuronox, Neuramis, a HA Dermal Filler marketed in Thailand for over 12 years, plays a crucial role. These core product lines form a foundation that enables Medyceles to expand its business and contribute to establishing standards and knowledge within the Thai aesthetic medicine industry.
Areeya Wuawong, Chief Operating Officer of Medyceles Co., Ltd., emphasized the company's strategic approach through four pillars: Quality, Accessible Price, Marketing Leadership, and Academic Excellence. The strategy aims to create value for clinics and patients while investing in knowledge, research, and medical training.
The 1 billion baht sales target reflects business growth and confidence among doctors, clinic partners, and consumers, particularly in core products like Neuronox and Neuramis. The Medyceles 360° Volume 4 event, under the theme "Crafted for Aesthetic Leaders Through Precision, Perspective and Experience," featured participation from over 1,000 doctors and aesthetic clinic operators. The event included Advanced Hands-on Training, Advanced Anatomy Training, a full-day academic conference, and Back to Basics Hands-on Training, providing doctors with a systematic review of fundamentals.
Knowledge about Botulinum Toxin was a focal point, covering anatomy, injection techniques, treatment planning, and safety guidelines. Key presentations included "10 Tips and Tricks That Truly Matter for Better Toxin Outcomes" by Dr. Paisarn Ramneethorn and "Precision Anatomy for Botulinum Toxin Injection: Enhancing Safety and Outcomes."
The event also featured leading doctors and experts from Thailand and abroad, including Dr. Susanna Marini from Italy, who shared insights on international trends in aesthetic medicine. A highlight was the disclosure of clinical study results for Neuramis Deep Lidocaine for lip contouring and wrinkle reduction, conducted in collaboration with Mahidol University and the Siriraj Skin Laser Center.
The Medyceles 360° Volume 4 event demonstrates Medyceles' commitment to building an ecosystem for the aesthetic medicine industry, leveraging core products Neuronox and Neuramis, research, and medical knowledge. The company aims to achieve its sales target while ensuring the sustainable growth of the Thai aesthetic medicine industry.